Screener
AMN Healthcare AMN Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by AMN Healthcare in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: AMN Healthcare’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054507
FAQ
- What is AMN Healthcare's cash & equivalents?
- AMN Healthcare (AMN) reported cash & equivalents of $390.48M in Q2 2026.
- How has AMN Healthcare's cash & equivalents changed year-over-year?
- AMN Healthcare's cash & equivalents increased by 439.0% year-over-year, from $72.45M to $390.48M.
- What is the long-term trend for AMN Healthcare's cash & equivalents?
- Over 5 years (2020 to 2025), AMN Healthcare's cash & equivalents has grown at a -4.4% compound annual growth rate (CAGR), from $83.99M to $67.17M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about AMN Healthcare's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude